Ugoos X5M Pro is a TV box based on Amlogic S905X5M chipset, which is one of the new budget chipsets from Amlogic (no VCC/H.266 support for instance). This box is similar if not identical to it’s older brothers from X4 family (reviewed here in the past), and the specs are simply upgraded. Aside for BT …
Ugoos AM9 is Ugoos’ newest offering, but like with SK series (SK1 to SK2), it takes a step back. From the powerful AM6 Pro and the AM8 (not sure where AM7 went), it goes to a cheaper chipset (Amlogic S905X5) with lighter specs. Many thanks goes to James from Ugoos for providing the AM9 Review …
Ugoos SK2 is Ugoos’ new budget Android TV box, and it’s a bit different than their other boxes. The biggest difference is the OS. SK2 uses Google Android TV at its core, and a realtek RTD1325 chipset. All of that is done to keep costs down, while still including licensing for the big streaming services. …
How Knives Out teaches Bayesian thinking (without you realizing it) The post Solving a Murder Mystery Using Bayesian Inference appeared first on Towards Data Science. Read More
Enterprise Document Intelligence [Vol. 1 #2bis] Why stacking a reranker on top of weak retrieval doesn’t save it, what cross-encoders actually fix vs what they don’t, and where the editorial position of the series lands. The post Rerankers Aren’t Magic Either: When the Cross-Encoder Layer Is Worth the Cost appeared first on Towards Data Science. …
Structure-guided NER optimization for enterprise GraphRAG systems The post Proxy-Pointer RAG: Eliminating Wasteful Entity & Relations Extraction in Knowledge Graphs appeared first on Towards Data Science. Read More
Daraxonrasib, which nearly doubled patients’ survival time, fights the disease in a new way. It bear-hugs a cancer protein that drives cell growth. Read More
Nature Medicine, Published online: 31 May 2026; doi:10.1038/s41591-026-04455-x As presented at the 2026 ASCO Annual Meeting, in a prespecified interim analysis of a phase 1a trial of IMA401—a new bispecific TCR-based T cell engager that binds a MAGE-A4/MAGE-A8 peptide presented by HLA-A*02:01—encouraging safety and a preliminary efficacy signal were observed in patients with head and …